Synchronous, Metachronous or Metastases?
Synchronous, Metachronous or Metastases?
Multiple primer lung cancer (MPAK) satellite tumors (accessory tumor of the same type with the same tumor in the same lobe) synchronoustumors (at the time of diagnosis, or at the same site within 3 months or with other tumors in the opposite lung) and metachronoustumors (a newly developed tumor in a patient with a definitively treated tumor). Satellite tumors are synchronous tumors also. It may bedifficult to understand whether MPAC is primer tumors originating from different areas of the lung, or whether they are metastases fromeach other. If the histopathological types of the tumors are different from each other, it can be said that they are generally MPAK. However,if histopathological types are the same, histopathological, molecular, genetic and clinical data are needed. It is useful to demonstratehistopathologically that the detailed analysis of tumors (subtype, dominant type, especially in adenocarcinomas) and carcioma insitubackground. Genetic and molecular tests are still a matter of debate. It is both very expensive and can be performed in a small numberof centers, and not at the expected activity. Because the cancer cells are very complex and constantly undergoing mutation and change.The clinical criteria, especially the Martini-Melamed criteria have been used for a long time. It is still valid. If the histopathological typesare different for metachronous tumors, there is no problem, but if they are the same, the second tumor is defined according to the developmenttime. However, it may be more accurate to evaluate these patients independently from time to time. The best survival data isobtained with surgery even if it is second cancer or local recurrence or metachronous cancer Therefore, if patients with synchronous ormetachronous cancer are considered to have no distant metastasis or mediastinal involvement, surgical treatment should be the priority.
___
- Shen KR, Meyers BF, Larner JM, Jones DR; American College of
Chest Physicians. Special treatment issues in lung cancer: ACCP evidence-based
clinical practice guidelines. Chest 2007; 132: 290-305.
[CrossRef]
- Deslauriers J, Brisson J, Cartier R, Fournier M, Gagnon D, Piraux M,
et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor
influencing prognosis after resection. J Thorac Cardiovasc Surg
1989; 97: 504-12.
- Shimizu N, Ando A, Date H, Teramoto S. Prognosis of undetected
intrapulmonary metastases in resected lung cancer. Cancer 1993;
71: 3868-72. [CrossRef]
- Trousse D, D’Journo XB, Avaro JP, Doddoli C, Giudicelli R, Fuentes
PA, et al. Multifocal T4 non-small cell lung cancer: a subset with
improved prognosis. Eur J Cardiothorac Surg 2008; 33: 99-103.
[CrossRef ]
- Keogan MT, Tung KT, Kaplan DK, Goldstraw PJ, Hansell DM. The significance
of pulmonary nodules detected on CT staging for lung
cancer. Clin Radiol 1993; 48: 94-6. [CrossRef]
- Oliaro A, Filosso PL, Cavallo A, Giobbe R, Mossetti C, Lyberis P, et al.
The significance of intrapulmonary metastasis in non-small cell lung
cancer: upstaging or downstaging? A re-appraisal for the next TNM
staging system. Eur J Cardiothorac Surg 2008; 34: 438-43. [CrossRef]
- Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK. Surgical
resection for multifocal (T4) non-small cell lung cancer: is the T4
designation valid? Ann Thorac Surg 2007; 83: 397-400. [CrossRef]
- Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging
system. Chest 2009; 136: 260-71. [CrossRef]
- Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS; American
College of Physicians. Lung Cancer. Special treatment issues. Chest
2003; 123: 244-58. [CrossRef]
- Martini N, Melamed MR. Multiple primary lung cancers. J Thorac
Cardiovasc Surg 1975; 70: 606-12.
- Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung
cancer. Ann Thorac Surg 1995; 59: 863-7. [CrossRef]
- Kim HL, Puymon MR, Qin M, Guru K, Mohler JL. NCCN clinical practice
guidelines in oncologyTM 2009.
- Kocaturk CI, Gunluoglu MZ, Cansever L, Dincer IS, Bedirhan MA.
Prognosis in patients with non-small cell lung cancer and satellite
tumors. Thorac Cardiovasc Surg 2011; 59: 360-3. [CrossRef]
- Beyreuther H. Multiplicität von Carcinomen bei einem fall von
sog.”Schneeberger” lungenkrebs mit tuberkulose. Virchows Arch
Pathol Anat Physiol Klin Med 1924; 250: 230-43. [CrossRef]
- De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck
D, Nafteux P, et al. Survival after resection of synchronous bilateral
lung cancer. Eur J Cardio-Thoracic Surg 2008; 34: 1215-22.
[CrossRef ]
- Aziz TM, Saad RA, Glasser J, Jilaihawi AN, Prakash D. The management
of second primary lung cancers. A single centre experience in
15 years. Eur J Cardio-Thoracic Surg 2002; 21: 527-33. [CrossRef]
- Detterbeck FC, Jones DR, Funkhouser WK. Satellite nodules and
multiple primary cancers. Diagnosis and treatment of lung cancer:
an evidence-based guide for the practicing clinician. WB Saunders,
Philadelphia, PA; 2001:437-49.
- Howe HL. A review of the definition for multiple primary cancers in
the United States. NAACCR. Proceedings from 2002 December 4-6;
Princeton, New Jersey.
19. Yang D. Build prognostic nomograms for risk assessment using SAS.
Proceedings from 2013; SAS
- Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk
C, et al. Prognostic nomogram to predict survival after surgery for
synchronous multiple lung cancers in multiple lobes. J Thorac Oncol
2015; 10: 338-45. [CrossRef]
- Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk
C, et al. Prognostic factors for survival after complete resections
of synchronous lung cancers in multiple lobes: pooled analysis
based on individual patient data. Ann Oncol 2012; 24: 889-94.
[CrossRef ]
- Trousse D, Barlesi F, Loundou A, Tasei AM, Doddoli C, Giudicelli R, et
al. Synchronous multiple primary lung cancer: an increasing clinical
occurrence requiring multidisciplinary management. J Thorac Cardiovasc
Surg 2007; 133: 1193-200. [CrossRef]
- Chang Y-L, Wu C-T, Lee Y-C. Surgical treatment of synchronous multiple
primary lung cancers: experience of 92 patients. J Thorac Cardiovasc
Surg 2007; 134: 630-7. [CrossRef]
- Nakata M, Sawada S, Yamashita M, Saeki H, Kurita A, Takashima S, et
al. Surgical treatments for multiple primary adenocarcinoma of the
lung. Ann Thorac Surg 2004; 78: 1194-9. [CrossRef]
- Mun M, Kohno T. Single-stage surgical treatment of synchronous
bilateral multiple lung cancers. Ann Thorac Surg 2007; 83: 1146-51.
[CrossRef]
- Rostad H, Strand T-E, Naalsund A, Norstein J. Resected synchronous
primary malignant lung tumors: a population-based study. Ann
Thorac Surg 2008; 85: 204-9. [CrossRef]
- Sherwood J, Dearden S, Ratcliffe M, Walker J. Mutation status concordance
between primary lesions and metastatic sites of advanced
non-small-cell lung cancer and the impact of mutation testing
methodologies: a literature review. J Exp Clin Cancer Res 2015; 34:
92. [CrossRef]
- Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, et al.
Analysis of mechanisms of acquired resistance to EGFR-TKI therapy
in 155 patients with EGFR-mutant lung Cancers. Clin Cancer Res
2013; 19: 2240-7. [CrossRef]
- Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide
allelotyping of lung cancer identifies new regions of allelic
loss, differences between small cell lung cancer and non-small
cell lung cancer, and loci clustering. Cancer Res 2000; 60: 4894-906.
- Warren S. Multiple primary malignant tumors. A survey of the literature
and a statistical study. Am J Cancer 1932; 16: 1358-414.
- Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt
WEE, et al. The IASLC lung cancer staging project: proposals
for revision of the TNM stage groupings in the forthcoming (eighth)
edition of the TNM classification for lung cancer. J Thorac Oncol
2016; 11: 39-51. [CrossRef]
- Mountain CF. Revisions in the international system for staging lung
cancer. Chest 1997; 111: 1710-7. [CrossRef]
- Rami-Porta R, Giroux DJ, Goldstraw P. The new TNM classification of
lung cancer in practice. Breathe 2011; 7348-60.
- Loukeri AA, Kampolis CF, Ntokou A, Tsoukalas G, Syrigos K. Metachronous
and synchronous primary lung cancers: diagnostic aspects,
surgical treatment, and prognosis. Clin Lung Cancer 2015; 16:
15-23. [CrossRef]
- Roberts PF, Straznicka M, Lara PN, Lau DH, Follette DM, Gandara DR,
et al. Resection of multifocal non-small cell lung cancer when the
bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg
2003; 126: 1597-601. [CrossRef]
- Shimada Y, Saji H, Otani K, Maehara S, Maeda J, Yoshida K, et al. Survival
of a surgical series of lung cancer patients with synchronous
multiple ground-glass opacities, and the management of their residual
lesions. Lung Cancer 2015; 88: 174-80. [CrossRef]
- Riquet M, Cazes A, Pfeuty K, Ngabou UD, Foucault C, Dujon A, et al.
Multiple lung cancers prognosis: what about histology? Ann Thorac
Surg 2008; 86: 921-6. [CrossRef]
- Voltolini L, Rapicetta C, Luzzi L, Ghiribelli C, Paladini P, Granato F, et
al. Surgical treatment of synchronous multiple lung cancer located
in a different lobe or lung: high survival in node-negative subgroup.
Eur J Cardiothoracic Surg 2010; 37: 1198-204. [CrossRef]
- Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ. Survival
after resection of synchronous non-small cell lung cancer. J Thorac
Cardiovasc Surg 2011; 142: 547-53. [CrossRef]
- Kocaturk CI, Gunluoglu MZ, Cansever L, Demir A, Cinar U, Dincer SI,
et al. Survival and prognostic factors in surgically resected synchronous
multiple primary lung cancers. Eur J Cardiothoracic Surg 2011;
39: 160-6. [CrossRef]
- van Rens MTM, Zanen P, de la Rivière AB, Elbers HRJ, van Swieten
HA, van den Bosch JMM. Survival after resection of metachronous
non-small cell lung cancer in 127 patients. Ann Thorac Surg 2001;
71: 309-13. [CrossRef]
- Tanvetyanon T, Robinson L, Sommers KE, Haura E, Kim J, Altiok S, et
al. Relationship between tumor size and survival among patients
with resection of multiple synchronous lung cancers. J Thorac Oncol
2010; 5: 1018-24. [CrossRef]
- Finley DJ, Yoshizawa A, Travis W, Zhou Q, Seshan VE, Bains MS, et
al. Predictors of outcomes after surgical treatment of synchronous
primary lung cancers. J Thorac Oncol 2010; 5: 197-205.
[CrossRef ]
- Okada M, Yamagishi H, Satake S, Matsuoka H, Miyamoto Y, Yoshimura
M, et al. Survival related to lymph node involvement in lung
cancer after sleeve lobectomy compared with pneumonectomy. J
Thorac Cardiovasc Surg 2000; 119: 814-9. [CrossRef]
- Rea F, Zuin A, Callegaro D, Bortolotti L, Guanella G, Sartori F. Surgical
results for multiple primary lung cancers. Eur J Cardio-Thoracic Surg
2001; 20: 489-95. [CrossRef]
- Armato SG, Roberts RY, Kocherginsky M, Aberle DR, Kazerooni EA,
Macmahon H, et al. Assessment of radiologist performance in the
detection of lung nodules: dependence on the definition of “truth”.
Acad Radiol 2009; 16: 28-38. [CrossRef]
- Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts
WM. Executive summary: diagnosis and management of lung cancer,3rd
ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest 2013; 143: 7-37. [CrossRef]
- Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment
issues in non-small cell lung cancer: Diagnosis and management
of lung cancer, 3rd ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest 2013; 143: e369S99S.
- Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps
C, et al. Survival after recurrent nonsmall-cell lung cancer after
complete pulmonary resection. Ann Thorac Surg 2007; 83: 409-18.
[CrossRef]
- Johnson BE, Cortazar P, Chute JP. Second lung cancers in patients
successfully treated for lung cancer. Semin Oncol 1997; 24: 492-9.
- Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE,
Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid
implications of recurrent disease. Ann Thorac Surg 1984; 38: 331-8.
[CrossRef]
- Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW,
et al. Incidence of local recurrence and second primary tumors in
resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109:
120-9. [CrossRef]
- Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, et al.
Post-recurrence survival in completely resected stage I non-small
cell lung cancer with local recurrence. Thorax 2009; 64: 192-6.
[CrossRef]
- Watanabe Y, Shimizu J, Oda M, Tatsuzawa Y, Hayashi Y, Iwa T. Second
surgical intervention for recurrent and second primary bronchogenic
carcinomas. Scand J Thorac Cardiovasc Surg 1992; 26: 73-8. [CrossRef]
- Dartevelle P, Khalife J. Surgical approach to local recurrence and
the second primary lesion. In: Delarue NC, Eschapasse H, editors.
International trends in general thoracic surgery. Vol 1. Philadelphia:
Saunders 1985; 156-63.
- Regnard JF, Icard P, Magdeleinat P, Jauffret B, Fares E, Levasseur P.
Completion pneumonectomy: experience in eighty patients. J Thorac
Cardiovasc Surg 1999; 117: 1095-101. [CrossRef]
- Zimmermann FB, Molls M, Jeremic B. Treatment of recurrent disease
in lung cancer. Semin Surg Oncol 2003; 21: 22-7. [CrossRef]
- Yano T, Hara N, Ichinose Y, Asoh H, Yokoyama H, Ohta M, et al. Local
recurrence after complete resection for non-small-cell carcinoma of
the lung: significance of local control by radiation treatment. J Thorac
Cardiovasc Surg 1994; 107: 8-12.
- Yoshino I, Yohena T, Kitajima M, Ushijima C, Nishioka K, Ichinose Y,
et al. Survival of non-small cell lung cancer patients with postoperative
recurrence at distant organs. Ann Thorac Cardiovasc Surg 2001;
7: 204-9.